CHINA KNOWLEDGE

China Knowledge is in the business of providing business solutions and products on China. Within the Group it has financial terminal, publishing, newswires, research, multimedia production and a wide range of consulting services offer to foreign businesses seeking opportunities in China.
Markets · IPO
Jiangsu Gdk Biotechnology debuts on SSE STAR Market, rose 50%
CKN
2021/08/02 08:40:21
3,429

Aug 02, 2021 (China Knowledge) - Jiangsu Gdk Biotechnology (688670) opened at RMB 88 on its first day trading on the Shanghai Stock Exchange's STAR Market, an increase of 59% from its IPO price of RMB 55.18.

The shares price ended the day at RMB 82.91, soaring 50% from its issue price. Its intraday high and low were RMB 100 and RMB 82.67, respectively. A total of 12.4 mln shares changed hands with a turnover of RMB 1.1 bln, and ending the day with a total market capitalization of RMB 7.3 bln.

Jiangsu Gdk Biotechnology reported in its prospectus that the funds raised from the IPO will be used to expand its production capacity, supplement its working capital, and to build a vaccine R&D center.

Copyright © 2018 www.chinaknowledge.com

Send feedback or comments to: info@chinaknowledge.com

For more news, financial weekly reports, business guides to China and other premium information, subscribe to China Knowledge today: www.chinaknowledge.com

To access our page on Bloomberg, type CKFI